November 22, 2021
Life Sciences
  • Pfizer Inc. and BioNTech SE said that their COVID-19 vaccine was 100 percent effective at preventing infections among adolescents ages 12 to 15 within four months of their second doses, and that the shot showed no safety concerns for at least six months afterward. The companies said they will use the longer-term results to seek full regulatory approval for the shot among people in that age range. (Article here)